Actavis to spend $66 billion on Allergan
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
Nov 17, 2014
0
0
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
Nov 17, 2014
0
0
(AP)—When swings in the stock market cause anxiety to spike, like it is now, many investors aim to get healthy.
Oct 16, 2014
0
0
Billions of neurons fire in the brains of stock market traders as they decide whether to buy or sell shares in a matter of seconds. Some of these brain waves produce rational calculations about how best to make a profit, ...
Jul 11, 2014
0
0
If you're so smart, why aren't you rich? It may be that, when it comes to stock market success, your brain is heeding the wrong neural signals.
Jul 7, 2014
2
1
AmSurg says it will spend about $2.35 billion to buy Sheridan Healthcare in a cash and stock deal that adds physician outsourcing services to the ambulatory surgery center operator's portfolio.
May 29, 2014
0
0
US drugs giant Pfizer wants a blockbuster merger with British rival AstraZeneca that will fuel cancer research, revealing on Monday that an informal approach worth almost $100 billion had been rejected.
Apr 28, 2014
0
0
India's third-biggest drugs company Sun Pharma announced Monday a $3.2-billion deal to buy larger domestic rival Ranbaxy from Daiichi Sankyo, ending the Japanese company's costly run as owner.
Apr 7, 2014
0
0
An hour's drive south of Canada's capital, past snow-covered pine forests and farmland, Chuck Rifici is growing marijuana at an old Hershey's factory.
Feb 16, 2014
0
0
Falling stock prices lead to increased hospitalisations for mental disorders, according to new research published today in the journal Health Policy and Planning.
Feb 13, 2014
0
0
Ranbaxy Laboratories, India's biggest generic drugmaker by sales, reported a narrower quarterly loss on Wednesday thanks to rising sales in key markets and currency gains.
Feb 5, 2014
0
0